Libo Sun
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Aging top 10%
Papers in
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 5
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Jian Li (4 shared papers)Qiuli Liang (1 shared paper)Bing Zhou (1 shared paper)Wei Li (1 shared paper)Juan Wang (1 shared paper)Weike Mo (1 shared paper)Xiuqing Huang (3 shared papers)Jichun Yang (2 shared papers)
In The Last Decade
Libo Sun
29 papers receiving 846 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 303
- Aging 22
- Epidemiology 124
- Molecular Biology 235
- Hepatology 31
Countries citing papers authored by Libo Sun
This map shows the geographic impact of Libo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libo Sun more than expected).
Fields of papers citing papers by Libo Sun
This network shows the impact of papers produced by Libo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libo Sun. The network helps show where Libo Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Libo Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 123 | |
| 2 | 2018 | 97 | |
| 3 | 2018 | 87 | |
| 4 | 2017 | 76 | |
| 5 | 2020 | 52 | |
| 6 | 2008 | 46 | |
| 7 | 2018 | 45 | |
| 8 | 2016 | 41 | |
| 9 | 2017 | 37 | |
| 10 | 2007 | 36 | |
| 11 | 2021 | 31 | |
| 12 | 2015 | 29 | |
| 13 | 2014 | 25 | |
| 14 | 2020 | 24 | |
| 15 | 2016 | 23 | |
| 16 | 2021 | 13 | |
| 17 | 2016 | 11 | |
| 18 | 2015 | 9 | |
| 19 | Down-expression of F box only protein 8 correlates with tumor grade and poor prognosis in human glioma. | 2014 | 8 |
| 20 | 2018 | 8 |
About Libo Sun
Libo Sun is a scholar working on Cancer Research, Hepatology, Molecular Biology, Epidemiology and Complementary and alternative medicine, having authored 29 papers that have together received 857 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers), Hepatitis B Virus Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Epigenetics and DNA Methylation (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Cancer Research (303 citations), Aging (22 citations), Epidemiology (124 citations), Molecular Biology (235 citations) and Hepatology (31 citations). Libo Sun has collaborated with scholars based in China, Canada and Nigeria. Frequent co-authors include Jian Li, Qiuli Liang, Bing Zhou, Wei Li, Juan Wang, Weike Mo, Xiuqing Huang, Jichun Yang, Weili Yang and Junpei Wang. Their work appears in journals such as Diabetes, Cellular Physiology and Biochemistry, Nature Communications, Molecular Biology of the Cell and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.